Denize Ainbinder serves as the Global PV RA Director at Medison Pharma since November 2022, overseeing regulatory affairs and pharmacovigilance strategies across various global markets. Previously, Denize held roles as PV RA Director for European Partner Markets and PV/RA Operations and Alliance Director. Denize is actively involved as a member of WE@HealthTech and 8400 The Health Network, and has been a lecturer at Ben-Gurion University of the Negev and a guest lecturer at The Hebrew University of Jerusalem. Denize's experience includes serving as Head of the Drug Registration Department and Deputy Head at the Ministry of Health in Israel. Educational qualifications include a Ph.D. in Pharmaceutics and Drug Design and an Executive education credential from Harvard Business School in health network leadership.